Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Biochim Biophys Acta. 2014 May 22;1842(9):1549–1555. doi: 10.1016/j.bbadis.2014.05.013

Figure 5. I-BET151 reduces onset and severity of EAE.

Figure 5

Mice were pretreated with 3 mg/kg I-BET151 for 3 days prior to immunization with MOG35–55 peptide and daily throughout the experiment. Clinical symptoms were scored daily and values shown are Means ± SEM. (n=4–5) *p<0.05, t-test. Data represent 1 out of 2 independent experiments